Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

AGEN 5.11 -0.17 (-3.22%)
price chart
Revenue Update on Agenus Inc.
Agenus Inc. (NASDAQ:AGEN) increased 3.73% or 0.19 points in todays market. Owing to the heightened optimism, Intraday the shares traded at a considerable range near the opening level of $5.09.
Why Shares of Agenus Inc Spiked
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Here Is Why Agenus Inc (NASDAQ:AGEN) Is Soaring  Bidness ETC
Where is Agenus Inc. (NASDAQ:AGEN) Headed?  Inside Trade
Why Agenus Inc. Stock Skyrocketed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Agenus Rallies On Brain Cancer Vaccine Results  Bidness Etc
Agenus brain cancer vaccine doubles survival rate in study  Reuters
Related articles »  
Agenus, Inc. - "2015: Poised To Be Another Transformative Year for Agenus"
Jan 12, 2015 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / January 12, 2015 / Agenus, Inc. AGEN, +4.95% today published a new blog post on The Chairman's Blog, written by the Company's Chairman and CEO, Dr.
Why Agenus Inc. Shares Tumbled
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
GSK's MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non-Small Cell ...  Business Wire (press release)
Agenus stock falls as partner GSK misses goals in lung cancer trial  Boston Business Journal (blog)
Related articles »  
Agenus Inc. Price Target Update
Agenus Inc. (NASDAQ:AGEN): 2 analysts have set the short term price target of Agenus Inc. (NASDAQ:AGEN) at $9. The standard deviation of short term price target has been estimated at $2.83, implying that the actual price may fluctuate by this value.
Thursday Stocks to Watch: Airgas Inc , Agenus Inc , ManpowerGroup Inc  Rock Hill Daily
First Call Rating Update on Agenus Inc
Agenus Inc (NASDAQ:AGEN) has been rated as Buy in the consensus report of First Call Corporation. The rating of the company was disclosed in the equity research recommendation.
Agenus (AGEN) Is Today's Dead Cat Bounce Stock  TheStreet.com
Why Agenus Inc. Stock Briefly Spiked Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Maxim Keeps Agenus (AGEN) at Buy, Comments on HerpV Phase 2 Results  StreetInsider.com (subscription)
UPDATE: Agenus Vaccine Shows Significant Reduction in Viral Burden after ...  Benzinga
Related articles »  
Agenus Inc Registers High Short Percent of Float
Agenus Inc (NASDAQ:AGEN) is in a strong bear grip; the short interest is registered high at 12.05% of the floated shares. Each share is trading at $4.83, which is merely 53% above the 52-week low and 25.6% below the 52-week high.
Agenus Inc Receives Average Target Price of $8.5  Wall Street Pulse
Small-caps That Should Be on Your Watchlist - Agenus Inc (NASDAQ:AGEN ...  Wall Street Observer
Today's Perilous Reversal Stock: Agenus (AGEN)
Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants.